VivoSim Labs, Inc. Other Current Liabilities
VivoSim Labs, Inc. (VIVS) had Other Current Liabilities of $9.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Other Liabilities, Current $9.00K.
- 2026-03-31: Other Liabilities, Current $36.00K.
- 2025-12-31: Other Liabilities, Current $16.00K.
- 2025-09-30: Other Liabilities, Current $9.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $36.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $16.00K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $9.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $10.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $59.00K 10-K · filed 2026-07-14 | |
| 2024-12-31 | $199.00K 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $61.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $82.00K 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $98.00K 10-K · filed 2025-06-05 | |
| 2023-12-31 | $191.00K 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $334.00K 10-Q · filed 2023-11-09 | |
| 2023-03-31 | $46.00K 10-K · filed 2024-05-31 | |
| 2022-03-31 | $28.00K 10-K · filed 2023-07-14 | |
| 2021-03-31 | $31.00K 10-K · filed 2022-06-10 | |
| 2020-03-31 | $21.00K 10-K · filed 2021-06-15 | |
| 2019-03-31 | $237.00K 10-K · filed 2020-05-28 | |
| 2018-03-31 | $507.00K 10-K · filed 2019-06-03 | |
| 2017-03-31 | $211.00K 10-K · filed 2018-05-31 | |
| 2016-03-31 | $61.00K 10-K · filed 2017-06-07 | |
| 2015-03-31 | $145.00K 10-K · filed 2016-06-09 | |
| 2014-03-31 | $34.00K 10-K · filed 2015-06-09 | |
| 2013-03-31 | $71.00K 10-K · filed 2014-06-10 | $124.00K 10-KT · filed 2013-05-24 |
| 2012-12-31 | $73.00K 10-K · filed 2014-06-10 | |
| 2011-12-31 | $92.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |